Ivermectin for the treatment of resistant scabies

Aaron M. Cook, Frank Romanelli, Homero A. Monsanto, Chantal Guévremont

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


OBJECTIVE: To assess the clinical literature describing the use of ivermectin in cases of treatment-resistant scabies infestations. DATA SOURCES: Clinical literature accessed through a MEDLINE search (1966-July 2001) and the Cochrane Database. DATA SYNTHESIS: A limited number of case reports and case series describes successful intervention with ivermectin use in patients who have failed prior therapy. Ivermectin may serve as a viable alternative therapy as the incidence of resistant scabitic infestations increases. CONCLUSIONS: Ivermectin appears to be a safe and effective alternative for patients with treatment-resistant scabies. Larger, controlled clinical trials are required before this therapy can be recommended in the general population or as primary therapy.

Original languageEnglish
Pages (from-to)279-281
Number of pages3
JournalAnnals of Pharmacotherapy
Issue number2
StatePublished - Feb 1 2003


  • Ivermectin
  • Resistance
  • Scabies

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Ivermectin for the treatment of resistant scabies'. Together they form a unique fingerprint.

Cite this